- Report
- September 2026
- 317 Pages
Global
From €5218EUR$5,850USD£4,474GBP
- Report
- October 2025
- 180 Pages
Global
From €4014EUR$4,500USD£3,441GBP
- Report
- July 2026
- 160 Pages
Global
From €2961EUR$3,320USD£2,539GBP
€3702EUR$4,150USD£3,174GBP
- Report
- October 2025
- 135 Pages
Global
From €4326EUR$4,850USD£3,709GBP
- Report
- May 2026
- 228 Pages
Global
From €4371EUR$4,900USD£3,747GBP
- Report
- January 2026
- 190 Pages
Global
From €3162EUR$3,545USD£2,711GBP
€3513EUR$3,939USD£3,012GBP
- Report
- January 2026
- 184 Pages
Global
From €3162EUR$3,545USD£2,711GBP
€3513EUR$3,939USD£3,012GBP
- Report
- January 2026
- 182 Pages
Global
From €4014EUR$4,500USD£3,441GBP
- Report
- January 2026
- 180 Pages
Global
From €4014EUR$4,500USD£3,441GBP
- Report
- September 2026
- 180 Pages
Global
From €3162EUR$3,545USD£2,711GBP
€3513EUR$3,939USD£3,012GBP
- Report
- September 2026
- 199 Pages
Global
From €3162EUR$3,545USD£2,711GBP
€3513EUR$3,939USD£3,012GBP
- Report
- September 2026
- 191 Pages
Global
From €3162EUR$3,545USD£2,711GBP
€3513EUR$3,939USD£3,012GBP
- Report
- September 2026
- 187 Pages
Global
From €3162EUR$3,545USD£2,711GBP
€3513EUR$3,939USD£3,012GBP
- Report
- September 2026
- 194 Pages
Global
From €3162EUR$3,545USD£2,711GBP
€3513EUR$3,939USD£3,012GBP
- Report
- September 2026
- 180 Pages
Global
From €3162EUR$3,545USD£2,711GBP
€3513EUR$3,939USD£3,012GBP
- Report
- September 2026
- 196 Pages
Global
From €3162EUR$3,545USD£2,711GBP
€3513EUR$3,939USD£3,012GBP
- Report
- September 2026
- 197 Pages
Global
From €3162EUR$3,545USD£2,711GBP
€3513EUR$3,939USD£3,012GBP
- Report
- September 2026
- 197 Pages
Global
From €3162EUR$3,545USD£2,711GBP
€3513EUR$3,939USD£3,012GBP
- Report
- September 2026
- 180 Pages
Global
From €3162EUR$3,545USD£2,711GBP
€3513EUR$3,939USD£3,012GBP
- Report
- September 2026
- 193 Pages
Global
From €3162EUR$3,545USD£2,711GBP
€3513EUR$3,939USD£3,012GBP

The Laboratory Developed Test (LDT) market is a subset of the laboratory testing industry. It is composed of tests that are designed, manufactured, and used within a single laboratory. These tests are not subject to the same regulatory requirements as tests that are commercially available. LDTs are often used to diagnose rare diseases, detect genetic mutations, and monitor therapeutic response.
LDTs are typically used in clinical settings, such as hospitals and physician offices, and are often used to supplement or replace commercially available tests. They are also used in research settings to develop new tests and to validate existing tests.
The LDT market is highly competitive, with many companies offering a wide range of tests. Some of the major players in the market include Quest Diagnostics, LabCorp, ARUP Laboratories, Mayo Medical Laboratories, and Eurofins Scientific. Show Less Read more